Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- sevelamer
- Trovan (trovafloxacin)
Interactions between your drugs
trovafloxacin sevelamer
Applies to: Trovan (trovafloxacin), sevelamer
ADJUST DOSING INTERVAL: Concurrent administration of sevelamer hydrochloride may decrease the oral bioavailability of ciprofloxacin and other quinolones, potentially reducing antibiotic efficacy and increasing the risk of bacterial resistance. The proposed mechanism is reduced quinolone absorption due to chelation with the protonated amine groups of sevelamer in the intestine. In 15 healthy volunteers, administration of sevelamer hydrochloride (7 X 403 mg capsules) followed immediately by a single dose of ciprofloxacin 750 mg resulted in decreased peak plasma concentration (Cmax) and relative oral bioavailability of ciprofloxacin by 27% and 48%, respectively, compared to administration of ciprofloxacin alone. The interaction was subject to a high degree of interindividual variation. Compared with ciprofloxacin alone, the relative oral bioavailability of ciprofloxacin ranged from 0.27 to 1.16 when coadministered with sevelamer. Two subjects had increased ciprofloxacin systemic exposure (AUC) with sevelamer. No data are available for other quinolones but a similar interaction should be expected.
MANAGEMENT: Oral quinolone antibiotics should not be administered simultaneously with sevelamer hydrochloride. The optimal length of time needed to separate ingestion of these drugs is currently unknown. Based on the fact that it took up to 4 hours to achieve ciprofloxacin Cmax in all 15 volunteers of the study, the authors suggested a separation time of at least 4 hours between sevelamer and ciprofloxacin administration to reduce the likelihood of a significant interaction, particularly in patients with end-stage renal disease whose gastrointestinal motility may be slowed.
References (1)
- Kays MB, Overholser BR, Mueller BA, Moe SM, Sowinski KM (2003) "Effects of sevelamer hydrochloride and calcium acetate on the oral bioavailability of ciprofloxacin." Am J Kidney Dis, 42, p. 1253-9
Drug and food interactions
sevelamer food
Applies to: sevelamer
ADJUST DOSING INTERVAL: Sevelamer may decrease the oral bioavailability of concomitantly administered drugs. While clinical data are lacking for most drugs, the intestinal absorption of some may be impaired due to sevelamer's binding capabilities.
MANAGEMENT: As a precaution, drugs that can be adversely affected by alterations in blood levels should be administered 1 hour before or 3 hours after sevelamer.
References (2)
- (2001) "Product Information. Renagel (sevelamer)." Genzyme Corporation
- (2002) "Product Information. Xatral (alfuzosin)." Sanofi-Synthelabo Canada Inc
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Carafate
Carafate is an anti-ulcer medication used to treat active duodenal ulcers. Learn about side ...
Renvela
Renvela (sevelamer) reduces blood levels of phosphorus in people with chronic kidney disease who ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Ibsrela
Ibsrela (tenapanor) is used for the treatment of irritable bowel syndrome with constipation ...
Auryxia
Auryxia is used for hyperphosphatemia of renal failure, iron deficiency anemia
Velphoro
Velphoro (sucroferric oxyhydroxide) is used to treat hyperphosphatemia in chronic kidney disease ...
Xphozah
Xphozah (tenapanor) is a phosphate absorption inhibitor that is used lower serum phosphorus levels ...
Fosrenol
Fosrenol (lanthanum carbonate) reduces phosphate levels in patients with end stage renal disease ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.